1. Home
  2. VTAK vs ALBT Comparison

VTAK vs ALBT Comparison

Compare VTAK & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • ALBT
  • Stock Information
  • Founded
  • VTAK 2002
  • ALBT 2014
  • Country
  • VTAK United States
  • ALBT United States
  • Employees
  • VTAK N/A
  • ALBT N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VTAK Health Care
  • ALBT Health Care
  • Exchange
  • VTAK Nasdaq
  • ALBT Nasdaq
  • Market Cap
  • VTAK 3.1M
  • ALBT 3.1M
  • IPO Year
  • VTAK 2018
  • ALBT N/A
  • Fundamental
  • Price
  • VTAK $0.35
  • ALBT $5.42
  • Analyst Decision
  • VTAK
  • ALBT
  • Analyst Count
  • VTAK 0
  • ALBT 0
  • Target Price
  • VTAK N/A
  • ALBT N/A
  • AVG Volume (30 Days)
  • VTAK 149.8K
  • ALBT 27.1K
  • Earning Date
  • VTAK 03-31-2025
  • ALBT 04-14-2025
  • Dividend Yield
  • VTAK N/A
  • ALBT N/A
  • EPS Growth
  • VTAK N/A
  • ALBT N/A
  • EPS
  • VTAK N/A
  • ALBT N/A
  • Revenue
  • VTAK $399,000.00
  • ALBT N/A
  • Revenue This Year
  • VTAK $38.46
  • ALBT N/A
  • Revenue Next Year
  • VTAK $533.33
  • ALBT N/A
  • P/E Ratio
  • VTAK N/A
  • ALBT N/A
  • Revenue Growth
  • VTAK 27.07
  • ALBT N/A
  • 52 Week Low
  • VTAK $0.31
  • ALBT $2.11
  • 52 Week High
  • VTAK $4.10
  • ALBT $21.60
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 34.81
  • ALBT 78.62
  • Support Level
  • VTAK $0.33
  • ALBT $3.33
  • Resistance Level
  • VTAK $0.43
  • ALBT $3.73
  • Average True Range (ATR)
  • VTAK 0.03
  • ALBT 0.35
  • MACD
  • VTAK -0.00
  • ALBT 0.19
  • Stochastic Oscillator
  • VTAK 17.00
  • ALBT 91.63

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: